# Bone Marrow Derived Mononuclear Cells for Ischemic Cardiomyopathy

> **NCT01144221** · NA · TERMINATED · sponsor: **Kai Jaquet, PhD, DSc** · enrollment: 6 (actual)

## Conditions studied

- Heart Disease

## Interventions

- **PROCEDURE:** Intramyocardial Cell therapy

## Key facts

- **NCT ID:** NCT01144221
- **Lead sponsor:** Kai Jaquet, PhD, DSc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-05
- **Primary completion:** 2013-05
- **Final completion:** 2015-02
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** funding issues
- **Last updated:** 2018-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01144221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01144221, "Bone Marrow Derived Mononuclear Cells for Ischemic Cardiomyopathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01144221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*